Regulatory submission for Class IIb CE Mark and ISO 13485 certification paves the way for European launch of Median’s AI-driven SaMD platform targeting early lung cancer detection....
Pioneering Clinical Study Evaluates Bioresorbable Endovascular Implant Aimed at Restoring Vascular Tissue and Preventing Amputation in PAD Patients...
New artificial intelligence tools enhance early identification of high-risk polyps, improving colorectal cancer prevention and patient outcomes....
World Economic Forum recognizes INBRAIN for its groundbreaking graphene-based brain-computer interface platform aimed at treating neurological disorders with unmatched precision....
Recognition highlights INBRAIN’s groundbreaking graphene-based neurotechnology advancing precision neuromodulation and brain–computer interface innovation ...
Innovative HealthTech Solutions to Be Showcased from June 25–27, Highlighting e4life’s Global Expansion and Preventive Care Focus...
Poised for rollout in the EU and US, the innovation aims to automate IV-line maintenance, reduce complications, and enhance patient safety across hospital and homecare settings. ...
Next-Gen Stroke Device Aims to Enhance Clot Removal and Improve Outcomes in Ischemic Stroke Treatment Across Europe...
Company Expands U.S. Commercial Operations to Strengthen Market Presence and Drive Adoption of Minimally Invasive Spine Solutions...
Next-gen portable ultrasound system combines speed, image clarity, and AI-powered tools to elevate diagnostic confidence at the bedside....
